改变子宫内膜异位症的「诊断范围」:无创标志物的新前沿
子宫内膜异位症影响九分之一女性,传统腹腔镜诊断常延迟。本文综述子宫内膜生物标志物、血液生物标志物及先进影像(超声与磁共振成像)的现状,指出目前尚无单一确定性标志物能高敏感度和高特异度诊断子宫内膜异位症,需更多研究推进其超越发现阶段。
要点
- 子宫内膜异位症影响九分之一女性,传统腹腔镜诊断常延迟。
- 目前尚无单一确定性生物标志物能以高敏感度和高特异度诊断子宫内膜异位症。
- 提高对无创影像和生物标志物的理解有助于更早识别子宫内膜异位症并考虑治疗选择。
核心结论
- 目前尚无单一确定性生物标志物能以高敏感度和高特异度诊断子宫内膜异位症,推进其超越发现阶段具有挑战性且需更多工作。
- 作者认为持续的研究、创新和开发将提高诊断准确性并指导子宫内膜异位症相关疼痛和不孕的最佳治疗。
研究设计与样本
- 本 issue 的 Views and Reviews 旨在总结子宫内膜异位症无创标志物的现状。
- 生殖医学领域有相关研究经验的专家总结了子宫内膜生物标志物、血液生物标志物和先进影像(包括超声和磁共振成像)的关键文献。
主要发现
- 子宫内膜异位症影响九分之一女性,传统腹腔镜诊断常延迟。
- 无创标志物有潜力实现更早诊断,从而更及时治疗和更好规划手术。
- 目前尚无单一确定性生物标志物能以高敏感度和高特异度诊断子宫内膜异位症。
临床怎么用
- 对无创影像和生物标志物有更好理解的临床医生将能更早、更容易地识别子宫内膜异位症,从而及时考虑治疗选择。
局限性
- 目前尚无单一确定性生物标志物能以高敏感度和高特异度诊断子宫内膜异位症。
- 推进子宫内膜异位症生物标志物超越发现阶段具有挑战性,且需更多工作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endometriosis affects 1 in 9 women, and diagnosis is often delayed using conventional laparoscopy. Noninvasive markers of endometriosis have the potential to enable earlier diagnosis, leading to more timely treatment and better surgical planning. This issue's Views and Reviews seek to summarize the current status of noninvasive markers of endometriosis. Experts in reproductive medicine with prior work in this field summarize the key literature on endometrial biomarkers, blood biomarkers, and advanced imaging, including ultrasound and magnetic resonance imaging. At present, there is no single definitive biomarker that can diagnose endometriosis with high sensitivity and specificity. Advancing endometriosis biomarkers beyond the discovery phase is challenging, and more work is needed. Clinicians who have an improved understanding of noninvasive imaging and biomarkers will be able to identify endometriosis earlier and more easily, allowing for prompt consideration of treatment options. We believe that continued research, innovation, and development will lead to improved diagnostic accuracy and guidance toward the best treatments for endometriosis-related pain and infertility.
引用
- Komorowski AS, Feinberg EC. Changing the "scope" of diagnosing endometriosis: the new frontier of noninvasive markers. Fertil Steril. 2023. PMID: 38104885. doi:10.1016/j.fertnstert.2023.12.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。